MedTrace Logo

The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia

NCT04374591 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2020-10-06

No results posted yet for this study

Summary

To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.

Conditions

Interventions

DRUG

Sodium Bicarbonate

Inhalation of Sodium Bicarbonate 8.4% via nebulizer

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Mohammed K Elbadrawy, PhD · Chest department Mansoura University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-11-01
Completion
2020-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04374591 on ClinicalTrials.gov